AstraZeneca Personalized Medicine Team has 10 Projects In The Clinic - McHale
This article was originally published in The Pink Sheet Daily
Executive Summary
Duncan McHale joined the firm in May as personalized health care medical director.
You may also be interested in...
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested
Pharma Gets 340B Appeals Court Victory But More Decisions Are Pending; Will Congress Step In?
Third Circuit is first of three federal appeals courts to issue a decision in multiple lawsuits over drug companies’ 340B contract pharmacy restrictions, which have led to conflicting lower court rulings on whether such restrictions are unlawful.
US Medicare Price Negotiation: Gaming FDA Approval Dates Could Delay Drug Selection
The early February date for publishing the list of products eligible for price negotiations could dictate approval strategies for drugs with potential for big sales in Medicare going forward.